What are Cumberland Pharmaceuticals's total assets?

Cumberland Pharmaceuticals (CPIX) holds $71.0M in total assets, up 1.5% year over year.

How much debt does Cumberland Pharmaceuticals have?

Cumberland Pharmaceuticals carries $4.8M in total debt against $21.6M of shareholders' equity, a debt-to-equity ratio of 0.22.

How much cash does Cumberland Pharmaceuticals have?

Cumberland Pharmaceuticals holds $11.0M in cash and equivalents.

Can Cumberland Pharmaceuticals cover its short-term obligations?

Its current ratio is 0.95 — current liabilities exceed current assets.

Where does Cumberland Pharmaceuticals's balance sheet data come from?

Every line is extracted from Cumberland Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Cumberland Pharmaceuticals CPIX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$11.01M-27.1%	$11.44M-36.3%	$15.2M-13.0%	$16.09M-7.2%	$15.11M-18.5%
Accounts receivable, net	$14.26M+36.0%	$16.94M+44.8%	$10.43M-7.8%	$10.32M-11.2%	$10.49M-1.5%
Inventories	$9.88M-0.6%	$9.25M-15.9%	$9.18M-22.4%	$9.53M-19.7%	$9.94M-23.0%
Raw materials	$10.06M-7.1%	$9.83M-17.9%	$9.75M-20.8%	$10.38M-18.2%	$10.83M-15.2%
Finished goods	$5.27M+75.1%	$5.65M+94.9%	$2.32M-40.2%	$2.26M-31.6%	$3.01M-29.0%
Prepaid expenses and other current assets	$2.07M-5.3%	$2.45M-12.2%	$1.38M-29.4%	$1.58M-32.1%	$2.18M-18.7%
Total current assets	$32.79M+2.9%	$37.06M+1.7%	$29.94M-15.0%	$31.21M-12.3%	$31.88M-12.0%
Property and equipment, net	$237.38K-20.5%	$264.72K-4.6%	$293.38K-6.0%	$297.79K-11.7%	$298.74K-19.1%
Operating lease right-of-use assets	9.4%0.0%	9.4%-617,692,291%	9.4%0.0%	9.4%0.0%	9.4%0.0%
Goodwill	$914K0.0%	$914K0.0%	$914K0.0%	$914K0.0%	$914K0.0%
Intangible assets, net	$12.79M-24.7%	$14.03M-22.0%	$15.01M-22.7%	$15.99M-21.9%	$16.99M-21.1%
Other non-current assets	$100K-50.0%	$2.97M+6.8%	$100K-50.0%	$200K0.0%	$200K0.0%
Long-term investments	——	——	——	——	——
Total assets	$71M+1.5%	$76.82M+1.6%	$65.9M-14.1%	$67.91M-13.5%	$69.94M-14.2%
Accounts payable	$16.54M+18.7%	$18.57M+33.4%	$13.83M+14.7%	$13.45M+7.5%	$13.93M+6.5%
Accrued expenses	$12.98M+15.7%	$12.64M+3.1%	$10.08M-20.3%	$10.14M-14.6%	$11.22M-13.6%
Current portion of long-term debt	——	——	——	——	——
Operating lease liabilities, current	$485.16K+30.7%	$467.77K+31.2%	$401.45K+2.5%	$386.08K+2.5%	$371.09K+2.4%
Total current liabilities	$34.49M+35.1%	$36.74M+16.2%	$24.31M-21.8%	$23.97M-3.2%	$25.52M-3.4%
Operating lease liabilities, non-current	$4.34M-10.0%	$4.47M-9.5%	$4.6M-8.0%	$4.71M-7.6%	$4.83M-7.1%
Operating Lease Liabilities (Total)	$4.83M-7.1%	$4.94M-6.7%	$5M-7.3%	$5.1M-6.9%	$5.2M-6.5%
Other non-current liabilities	$5.62M-6.4%	$5.82M-7.6%	$5.95M-2.3%	$6.3M-3.6%	$6.01M-9.1%
Total liabilities	$49.69M+19.5%	$52.28M-1.4%	$40.1M-23.3%	$40.23M-23.4%	$41.6M-23.4%
Common stock	$51.73M+0.7%	$51.68M+10.4%	$51.51M+10.0%	$51.44M+9.8%	$51.37M+9.5%
Retained earnings	-$30.09M-32.5%	-$26.8M-11.8%	-$25.39M-15.1%	-$23.45M-14.3%	-$22.71M-16.9%
Noncontrolling interests	-$333.51K-5.4%	-$336.1K-9.3%	-$319.15K-3.1%	-$310.87K+1.9%	-$316.4K-5.5%
Total stockholders' equity	$21.64M-24.5%	$24.88M+8.9%	$26.12M+5.4%	$27.99M+6.2%	$28.66M+4.2%
Total liabilities and stockholders' equity	$71M+1.5%	$76.82M+1.6%	$65.9M-14.1%	$67.91M-13.5%	$69.94M-14.2%
Finished goods	$5.27M+75.1%	$5.65M+94.9%	$2.32M-40.2%	$2.26M-31.6%	$3.01M-29.0%
Work in process and raw materials	$10.06M-7.1%	$9.83M-17.9%	$9.75M-20.8%	$10.38M—	$10.83M—
Operating Lease Receivables (Current)	——	——	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$2.93M+6.7%	$2.97M+6.8%	$2.99M+5.6%	$2.85M-4.8%	$2.74M-10.4%
Net Investment in Lease	$100K-50.0%	$8.34M+35.1%	$100K-50.0%	$200K0.0%	$200K0.0%
Net Operating Loss Carryforwards	——	——	——	——	——
Intangible assets — net	$12.79M-24.7%	$14.03M-22.0%	$15.01M-22.7%	$15.99M-21.9%	$16.99M-21.1%
Investments	——	——	——	——	——
Operating lease right-of-use assets	$7.62M+6.1%	$8.34M+35.1%	$7.57M+21.9%	$7.13M+11.9%	$7.18M+10.1%
Other non-current assets	$2.93M+6.7%	$2.97M+6.8%	$2.99M+5.6%	$2.85M-4.8%	$2.74M-10.4%
Operating Lease Right-of-Use Assets in Other Assets	$7.62M+6.1%	$8.34M+35.1%	$7.57M+21.9%	$7.13M+11.9%	$7.18M+10.1%
Software and Technology Licenses, Net	$2.93M+6.7%	$2.97M+6.8%	$2.99M+5.6%	$2.85M-4.8%	$2.74M-10.4%
Other accrued liabilities	$12.98M+15.7%	$12.64M+3.1%	$10.08M-20.3%	$10.14M-14.6%	$11.22M-13.6%
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	——	——	——	——
Lease Liability Payments - Due Year Two	——	——	——	——	——
Lease Liability Payments - Due Year Three	——	——	——	——	——
Lease Liability Payments - Due Year Four	——	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——	——
Line of Credit Outstanding	$5.24M—	$5.24M-48.5%	$0-100%	$0-100%	$0-100%
Operating Lease Liability Payments Due	——	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	——	——	——	——
Operating Lease Liability Payments - 2027 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	——	——	——	——
Total debt	$4.83M-7.1%	$4.94M-52.5%	$5M-7.3%	$5.1M-6.9%	$5.2M-6.5%
Common Stock Par Value Per Share	$0.00—	——	——	——	——
Common Stock Shares Issued	15M+0.1%	15M+7.2%	15M+6.8%	15M+6.2%	15M+5.7%
Share Repurchase Authorization Limit	——	——	——	——	——
Share Repurchase Program - Amount Remaining	——	——	——	——	——
Common stock, par value (in dollars per share)	$0—	——	——	——	——
Common stock, shares authorized (in shares)	$100M0.0%	$100M0.0%	$100M0.0%	$100M0.0%	$100M0.0%
Common stock, shares issued (in shares)	$14.98M+0.1%	$14.96M+7.2%	$14.96M+6.8%	$14.96M+6.2%	$14.96M+5.7%
Common Stock, Shares, Outstanding	$14.98M+0.1%	$14.96M+7.2%	$14.96M+6.8%	$14.96M+6.2%	$14.96M+5.7%
Investment-related Liabilities	——	——	——	——	——
Lessee Operating Lease Liability Payments Due	——	——	——	——	——
After 2030	——	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	——	——	——
Rent increase	——	——	——	——	——
Secured lines of credit	$5.24M0.0%	$5.24M-48.5%	$5.24M-48.1%	$5.24M-67.4%	$5.24M-67.4%
Noncontrolling interests in subsidiaries	-$333.51K-5.4%	-$336.1K-9.3%	-$319.15K-3.1%	-$310.87K+1.9%	-$316.4K-5.5%
Operating Lease Weighted Average Discount Rate Percent	$0.09-0.2%	$0.09-0.2%	$0.09—	$0.09—	$0.09—
Operating Loss Carryforwards	——	——	——	——	——
Share Repurchase Program, Remaining Authorized, Amount	——	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Cumberland Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Cumberland Pharmaceuticals's total assets?: Cumberland Pharmaceuticals (CPIX) holds $71.0M in total assets, up 1.5% year over year.
How much debt does Cumberland Pharmaceuticals have?: Cumberland Pharmaceuticals carries $4.8M in total debt against $21.6M of shareholders' equity, a debt-to-equity ratio of 0.22.
How much cash does Cumberland Pharmaceuticals have?: Cumberland Pharmaceuticals holds $11.0M in cash and equivalents.
Can Cumberland Pharmaceuticals cover its short-term obligations?: Its current ratio is 0.95 — current liabilities exceed current assets.
Where does Cumberland Pharmaceuticals's balance sheet data come from?: Every line is extracted from Cumberland Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.